Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trial
Andrea Sartore‐Bianchi(University of Milan), Alberto Bardelli(IFOM), Elisabetta Fenocchio(Candiolo Cancer Institute), Giovanni Crisafulli(IFOM), Gianluca Mauri(University of Milan), Enrico Berrino(Candiolo Cancer Institute), Benedetta Mussolin(Candiolo Cancer Institute), Francesca Bergamo(Istituto Oncologico Veneto), Salvatore Siena(University of Milan), Alessio Amatu(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Francesca Daniel(Istituto Oncologico Veneto), Angelo Vanzulli(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Paolo Manca(Fondazione IRCCS Istituto Nazionale dei Tumori), Sara Lonardi(Istituto Oncologico Veneto), Federica Tosi(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Alice Bartolini(Candiolo Cancer Institute), Caterina Marchiò(Candiolo Cancer Institute), Daniele Regge(Candiolo Cancer Institute), Filippo Pietrantonio(Fondazione IRCCS Istituto Nazionale dei Tumori), Silvia Marsoni(IFOM), Francesco Rua(Candiolo Cancer Institute), Anna Sapino(Candiolo Cancer Institute), Margherita Ambrosini(Assistance Publique – Hôpitaux de Paris), Giovanni Cappello(Candiolo Cancer Institute), Valter Torri(Istituti di Ricovero e Cura a Carattere Scientifico)
Cited by 259
Related Papers
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
|The Lancet Oncology|2017|2.8k
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer
|Journal of Clinical Oncology|2018|2.1k
Encorafenib, Binimetinib, and Cetuximab in <i>BRAF</i> V600E–Mutated Colorectal Cancer
|New England Journal of Medicine|2019|1.5k